2020 Clinical Practice Guideline for Percutaneous Transthoracic Needle Biopsy of Pulmonary Lesions: A Consensus Statement and Recommendations of the Korean Society of Thoracic Radiology

다국어 초록 (Multilingual Abstract)

Percutaneous transthoracic needle biopsy (PTNB) is one of the essential diagnostic procedures for pulmonary lesions. Its role is increasing in the era of CT screening for lung cancer and precision medicine. The Korean Society of Thoracic Radiology developed the first evidence-based clinical guideline for PTNB in Korea by adapting pre-existing guidelines. The guideline provides 39 recommendations for the following four main domains of 12 key questions: the indications for PTNB, pre-procedural evaluation, procedural technique of PTNB and its accuracy, and management of post-biopsy complications. We hope that these recommendations can improve the diagnostic accuracy and safety of PTNB in clinical practice and promote standardization of the procedure nationwide.

참고문헌 (Reference)

1 Alkadhi H, "Vascular emergencies of the thorax after blunt and iatrogenic trauma: multi-detector row CT and threedimensional imaging" 24 : 1239-1255, 2004

2 Lee MH, "Ultrasound guidance versus CT guidance for peripheral lung biopsy:performance according to lesion size and pleural contact" 210 : W110-W117, 2018

3 Jeon KN, "US-guided transthoracic biopsy of peripheral lung lesions:pleural contact length influences diagnostic yield" 55 : 295-301, 2014

4 Kim L, "Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?" 44 : 1011-1022, 2014

5 Whigham CJ Jr, "Traumatic injury of the internal mammary artery: embolization versus surgical and nonoperative management" 9 : 201-207, 2002

6 Nam BD, "Transthoracic rebiopsy for mutation analysis in lung adenocarcinoma: outcomes and risk factors for the acquisition of nondiagnostic specimens in 199 patients" 20 : e309-e316, 2019

7 Cox JE, "Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax" 212 : 165-168, 1999

8 Khouri NF, "Transthoracic needle aspiration biopsy of benign and malignant lung lesions" 144 : 281-288, 1985

9 Lee SM, "Transient part-solid nodules detected at screening thinsection CT for lung cancer: comparison with persistent partsolid nodules" 255 : 242-251, 2010

10 Chemelli AP, "Transcatheter arterial embolization for the management of iatrogenic and blunt traumatic intercostal artery injuries" 49 : 1505-1513, 2009

11 Perlmutt LM, "Timing of chest film follow-up after transthoracic needle aspiration" 146 : 1049-1050, 1986

12 Lim WH, "Time-dependent analysis of incidence, risk factors and clinical significance of pneumothorax after percutaneous lung biopsy" 28 : 1328-1337, 2018

13 Chaffey MH, "The role of percutaneous lung biopsy in the workup of a solitary pulmonary nodule" 148 : 176-181, 1988

14 Lordan JL, "The pulmonary physician in critical care · illustrative case 7: assessment and management of massive haemoptysis" 58 : 814-819, 2003

15 Saji H, "The incidence and the risk of pneumothorax and chest tube placement after percutaneous CT-guided lung biopsy:the angle of the needle trajectory is a novel predictor" 121 : 1521-1526, 2002

16 National Institute for Health and Clinical Excellence, "The diagnosis and treatment of lung cancer (update). Clinical guideline 121 [CG121]"

17 El-Deiry WS, "The current state of molecular testing in the treatment of patients with solid tumors, 2019" 69 : 305-343, 2019

18 Patel IJ, "Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous imageguided interventions-part II: recommendations: endorsed by the canadian association for interventional radiology and the cardiovascular and interventional Radiological Society of Europe" 30 : 1168-1184.e1, 2019

19 Jekunen AP, "Role of rebiopsy in relapsed non-small cell lung cancer for directing oncology treatments" 2015 : 809835-, 2015

20 Ahn SY, "Risk of pleural recurrence after percutaneous transthoracic needle biopsy in stage I non-small-cell lung cancer" 29 : 270-278, 2019

21 Matsuguma H, "Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer" 80 : 2026-2031, 2005

22 Yeow KM, "Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies" 126 : 748-754, 2004

23 Yeow KM, "Risk factors for pneumothorax and bleeding after CT-guided percutaneous coaxial cutting needle biopsy of lung lesions" 12 : 1305-1312, 2001

24 Hwang EJ, "Risk factors for haemoptysis after percutaneous transthoracic needle biopsies in 4,172 cases: focusing on the effects of enlarged main pulmonary artery diameter" 28 : 1410-1419, 2018

25 Kim H, "Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection" 28 : 861-868, 2018

26 Yoon HJ, "Repeat biopsy for mutational analysis of non-small cell lung cancers resistant to previous chemotherapy: adequacy and complications" 265 : 939-948, 2012

27 National Lung Screening Trial Research Team, "Reduced lung-cancer mortality with low-dose computed tomographic screening" 365 : 395-409, 2011

28 O’Neill AC, "Rapid needle-out patient-rollover time after percutaneous CT-guided transthoracic biopsy of lung nodules:effect on pneumothorax rate" 262 : 314-319, 2012

29 Austin JH, "Radiologic implications of the 2011 classification of adenocarcinoma of the lung" 266 : 62-71, 2013

30 Steele JR, "Quality initiatives: establishing an interventional radiology patient radiation safety program" 32 : 277-287, 2012

31 Mahammedi A, "Pulmonary artery measurements in pulmonary hypertension: the role of computed tomography" 28 : 96-103, 2013

32 Pastorino U, "Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy" 30 : 1162-1169, 2019

33 McWilliams A, "Probability of cancer in pulmonary nodules detected on first screening CT" 369 : 910-919, 2013

34 Balata H, "Prevention and early detection for NSCLC: advances in thoracic oncology 2018" 14 : 1513-1527, 2019

35 Reck M, "Precision diagnosis and treatment for advanced non-small-cell lung cancer" 377 : 849-861, 2017

36 조예슬, "Practice Pattern of Transthoracic Needle Biopsy: 2016 Survey in the Members of Korean Society of Thoracic Radiology" 대한영상의학회 18 (18): 1005-1011, 2017

37 Huo YR, "Post-biopsy manoeuvres to reduce pneumothorax incidence in CT-guided transthoracic lung biopsies: a systematic review and metaanalysis" 42 : 1062-1072, 2019

38 Wiener RS, "Populationbased risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records" 155 : 137-144, 2011

39 Sconfienza LM, "Pleural and peripheral lung lesions:comparison of US- and CT-guided biopsy" 266 : 930-935, 2013

40 Lee C, "Percutaneous lung biopsy in the molecular profiling era: a survey of current practices" 32 : 63-67, 2017

41 Cronin CG, "Percutaneous lung biopsy after pneumonectomy: factors for improving success in the care of patients at high risk" 196 : 929-934, 2011

42 Richardson CM, "Percutaneous lung biopsies: a survey of UK practice based on 5444 biopsies" 75 : 731-735, 2002

43 Winn N, "Patient reported experiences of CT guided lung biopsy: a prospective cohort study" 9 : 53-, 2014

44 김형진, "Open Bronchus Sign on CT: A Risk Factor for Hemoptysis after Percutaneous Transthoracic Biopsy" 대한영상의학회 19 (19): 880-887, 2018

45 Lee KH, "Nondiagnostic percutaneous transthoracic needle biopsy of lung lesions: a multicenter study of malignancy risk" 290 : 814-823, 2019

46 Kim JI, "Non-specific benign pathological results on transthoracic core-needle biopsy: how to differentiate false-negatives?" 27 : 3888-3895, 2017

47 Chae KJ, "Non-diagnostic results of percutaneous transthoracic needle biopsy: a meta-analysis" 9 : 12428-, 2019

48 Tokaca N, "Molecular adequacy of image-guided rebiopsies for molecular retesting in advanced non-small cell lung cancer: a single-center experience" 13 : 63-72, 2018

49 최솔지, "Methodology for Developing Evidence-Based Clinical Imaging Guidelines: Joint Recommendations by Korean Society of Radiology and National Evidence-Based Healthcare Collaborating Agency" 대한영상의학회 18 (18): 208-216, 2017

50 Planchard D, "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 29 (29): iv192-iv237, 2018

51 Guralnik L, "Metabolic PET/CT-guided lung lesion biopsies: impact on diagnostic accuracy and rate of sampling error" 56 : 518-522, 2015

52 Davidson K, "Managing massive hemoptysis" 157 : 77-88, 2020

53 Håkanson E, "Management of life-threatening haemoptysis" 88 : 291-295, 2002

54 Scottish Intercollegiate Guidelines Network, "Lung cancer: diagnosis and management"

55 Hiraki T, "Incidence of and risk factors for pneumothorax and chest tube placement after CT fluoroscopy-guided percutaneous lung biopsy: retrospective analysis of the procedures conducted over a 9-year period" 194 : 809-814, 2010

56 Choi CM, "Incidence and risk factors of delayed pneumothorax after transthoracic needle biopsy of the lung" 126 : 1516-1521, 2004

57 Anzidei M, "Imaging-guided chest biopsies: techniques and clinical results" 8 : 419-428, 2017

58 Ziser A, "Hyperbaric oxygen therapy for massive arterial air embolism during cardiac operations" 117 : 818-821, 1999

59 Manhire A, "Guidelines for radiologically guided lung biopsy" 58 : 920-936, 2003

60 MacMahon H, "Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017" 284 : 228-243, 2017

61 van Hulst RA, "Gas embolism:pathophysiology and treatment" 23 : 237-246, 2003

62 Coulter TD, "Gas embolism" 342 : 2000-2002, 2000

63 Muth CM, "Gas embolism" 342 : 476-482, 2000

64 Tai R, "Frequency and severity of pulmonary hemorrhage in patients undergoing percutaneous CT-guided transthoracic lung biopsy: single-institution experience of 1175 cases" 279 : 287-296, 2016

65 Kurban LA, "Fluoroscopy-guided percutaneous lung biopsy: a valuable alternative to computed tomography" 49 : 876-882, 2008

66 Balter S, "Fluoroscopically guided interventional procedures: a review of radiation effects on patients’ skin and hair" 254 : 326-341, 2010

67 Tsai EB, "Feasibility and safety of intrathoracic biopsy and repeat biopsy for evaluation of programmed cell death ligand-1 expression for immunotherapy in non-small cell lung cancer" 287 : 326-332, 2018

68 Ko JP, "Factors influencing pneumothorax rate at lung biopsy:are dwell time and angle of pleural puncture contributing factors?" 218 : 491-496, 2001

69 Purandare NC, "F-18-FDG PET/CT-directed biopsy: does it offer incremental benefit?" 34 : 203-210, 2013

70 Detterbeck FC, "Executive summary: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines" 143 (143): 7S-37S, 2013

71 Gould MK, "Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines" 143 : e93S-e120S, 2013

72 Rivera MP, "Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines" 143 (143): e142S-e165S, 2013

73 Hsu JC, "Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study" 9 : e022293-, 2019

74 Song YS, "Does antiplatelet therapy increase the risk of hemoptysis during percutaneous transthoracic needle biopsy of a pulmonary lesion?" 200 : 1014-1019, 2013

75 Lee HN, "Diagnostic performance of CT-guided percutaneous transthoracic core needle biopsy using low tube voltage (100kVp): comparison with conventional tube voltage (120 kVp)" 59 : 425-433, 2018

76 이경희, "Diagnostic Accuracy of Percutaneous Transthoracic Needle Lung Biopsies: A Multicenter Study" 대한영상의학회 20 (20): 1300-1310, 2019

77 Solomon SB, "Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis" 194 : 266-269, 2010

78 Patel IJ, "Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions" 23 : 727-736, 2012

79 Hwang EJ, "Cone beam computed tomography virtual navigation-guided transthoracic biopsy of small (≤ 1 cm) pulmonary nodules:impact of nodule visibility during real-time fluoroscopy" 91 : 20170805-, 2018

80 Heerink WJ, "Complication rates of CT-guided transthoracic lung biopsy: meta-analysis" 27 : 138-148, 2017

81 Min JW, "Clinical significance of non-diagnostic pathology results from percutaneous transthoracic needle lung biopsy: experience of a tertiary hospital without an on-site cytopathologist" 14 : 1042-1050, 2009

82 Beck KS, "CTguided coaxial biopsy of malignant lung lesions: are cores from 20-gauge needle adequate for histologic diagnosis and molecular analysis?" 11 : 753-765, 2019

83 Geraghty PR, "CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate" 229 : 475-481, 2003

84 Tomiyama N, "CT-guided needle biopsy of lung lesions:a survey of severe complication based on 9783 biopsies in Japan" 59 : 60-64, 2006

85 Drumm O, "CT-guided lung biopsy: effect of biopsy-side down position on pneumothorax and chest tube placement" 292 : 190-196, 2019

86 Lim C, "CT-guided core biopsy of malignant lung lesions: how many needle passes are needed?" 57 : 652-656, 2013

87 Kim GR, "CT fluoroscopy-guided lung biopsy versus conventional CT-guided lung biopsy: a prospective controlled study to assess radiation doses and diagnostic performance" 21 : 232-239, 2011

88 Lee SM, "CT assessment-based direct surgical resection of part-solid nodules with solid component larger than 5 mm without preoperative biopsy: experience at a single tertiary hospital" 27 : 5119-5126, 2017

89 Lee SM, "C-arm cone-beam CT-guided percutaneous transthoracic needle biopsy of lung nodules: clinical experience in 1108 patients" 271 : 291-300, 2014

90 Kim H, "Bronchovascular injury associated with clinically significant hemoptysis after CT-guided core biopsy of the lung: radiologic and histopathologic analysis" 13 : e0204064-, 2018

91 Callister ME, "British thoracic society guidelines for the investigation and management of pulmonary nodules" 70 (70): ii1-ii54, 2015

92 Callister ME, "British Thoracic Society guidelines for the investigation and management of pulmonary nodules" 70 (70): ii1-ii54, 2015

93 Pinstein ML, "Avoidance of negative percutaneous lung-biopsy using contrast-enhanced CT" 140 : 265-267, 1983

94 Lalli AF, "Aspiration biopsy of thoracic lesions" 22 : 404-407, 1967

95 윤순호, "Analysis of Complications of Percutaneous Transthoracic Needle Biopsy Using CT-Guidance Modalities In a Multicenter Cohort of 10568 Biopsies" 대한영상의학회 20 (20): 323-331, 2019

96 Tavare AN, "A survey of UK percutaneous lung biopsy practice: current practices in the era of early detection, oncogenetic profiling, and targeted treatments" 73 : 800-809, 2018

97 Chen Y, "A reporting tool for practice guidelines in health care:the RIGHT statement" 166 : 128-132, 2017

98 강미진, "2018 Korean Clinical Imaging Guideline for Hemoptysis" 대한영상의학회 19 (19): 866-871, 2018